| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Medicine*
and
Pathology
and the Manitoba Institute of Cell
Biology,
University of Manitoba, Winnipeg,
Manitoba, Canada; the Department of Pathology,§
University of Alabama at Birmingham, Birmingham, Alabama; and the
Division of Hematology/Oncology,¶
Cornell
Medical Center, New York, New York
Transforming growth factor-ß-1 (TGF-ß1) is secreted by cells in a latent form (L-TGF-ß1) noncovalently bound to a latency-associated peptide. Activated alveolar macrophages obtained from rat lungs after bleomycin-induced pulmonary injury released increased amounts of active TGF-ß1 as well as plasmin, a protease, and thrombospondin-1 (TSP-1), a trimeric glycoprotein. Previously we had demonstrated that plasmin was critical to the activation of L-TGF- ß1. In the present study we demonstrated that TSP-1 is also important for the activation of L-TGF- ß1 because the activation can be inhibited by anti-TSP-1 monoclonal antibody. Proteins obtained from alveolar macrophage cell lysates immunoprecipitated with antibodies specific for TSP-1 were identified on immunoblots as LAP and TGF-ß1, indicating that TSP-1/L-TGF-ß1 complexes are present on alveolar macrophages. However, in the presence of plasmin both latency-associated peptide and TGF-ß1 were decreased in the same cell lysates, indicating that L-TGF-ß1 associated with TSP-1 is released by plasmin. Using immunofluorescence and antibodies to TGF-ß1 and CD36, a receptor for TSP-1, there was colocalization of TGF-ß1 with CD36. Because TSP-1 but not TGF-ß1 is a natural ligand for CD36, these findings suggest that the L-TGF-ß1 in a complex with TSP-1 localizes to the macrophage cell surface when TSP-1 interacts with its receptor, CD36. Furthermore, the association of TSP-1/L-TGF-ß1 complex with CD36 is necessary to the activation of L-TGF-ß1 because antibodies to CD36 prevent the colocalization of TGF-ß1 with CD36 as observed by immunofluorescence and inhibit activation of the L-TGF-ß1 by explanted alveolar macrophages. These findings suggest that activation of L-TGF-ß1 by plasmin occurs at the cell surface of activated alveolar macrophages and requires a TSP-1/CD36 interaction.
This article has been cited by other articles:
 |
|
 |
|
  H Wang, Z Su, and J Schwarze Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation Thorax, April 1, 2009; 64(4): 283 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhou, K. Koli, J. S. Hagood, M. Miao, M. Mavalli, D. B. Rifkin, and J. E. Murphy-Ullrich Latent Transforming Growth Factor-{beta}-Binding Protein-4 Regulates Transforming Growth Factor-{beta}1 Bioavailability for Activation by Fibrogenic Lung Fibroblasts in Response to Bleomycin Am. J. Pathol., January 1, 2009; 174(1): 21 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Liu and A. I. Gotlieb Transforming Growth Factor-{beta} Regulates in Vitro Heart Valve Repair by Activated Valve Interstitial Cells Am. J. Pathol., November 1, 2008; 173(5): 1275 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Wrzesinski, Y. Y. Wan, and R. A. Flavell Transforming Growth Factor-{beta} and the Immune Response: Implications for Anticancer Therapy Clin. Cancer Res., September 15, 2007; 13(18): 5262 - 5270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Hilchey, A. De, L. M. Rimsza, R. B. Bankert, and S. H. Bernstein Follicular Lymphoma Intratumoral CD4+CD25+GITR+ Regulatory T Cells Potently Suppress CD3/CD28-Costimulated Autologous and Allogeneic CD8+CD25- and CD4+CD25- T Cells J. Immunol., April 1, 2007; 178(7): 4051 - 4061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Masli, B. Turpie, and J W. Streilein Thrombospondin orchestrates the tolerance-promoting properties of TGF{beta}-treated antigen-presenting cells Int. Immunol., May 1, 2006; 18(5): 689 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Cho, M. J. Kang, R. J. Homer, H. R. Kang, X. Zhang, P. J. Lee, J. A. Elias, and C. G. Lee Role of Early Growth Response-1 (Egr-1) in Interleukin-13-induced Inflammation and Remodeling J. Biol. Chem., March 24, 2006; 281(12): 8161 - 8168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Myers, M. Croft, B. S. Kwon, R. S. Mittler, and A. T. Vella Peptide-Specific CD8 T Regulatory Cells Use IFN-{gamma} to Elaborate TGF-{beta}-Based Suppression J. Immunol., June 15, 2005; 174(12): 7625 - 7632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Mimura, H. Ihn, M. Jinnin, Y. Asano, K. Yamane, and K. Tamaki Constitutive Thrombospondin-1 Overexpression Contributes to Autocrine Transforming Growth Factor-{beta} Signaling in Cultured Scleroderma Fibroblasts Am. J. Pathol., May 1, 2005; 166(5): 1451 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhou, J. S. Hagood, and J. E. Murphy-Ullrich Thy-1 Expression Regulates the Ability of Rat Lung Fibroblasts to Activate Transforming Growth Factor-{beta} in Response to Fibrogenic Stimuli Am. J. Pathol., August 1, 2004; 165(2): 659 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Torrealba, M. Katayama, J. H. Fechner Jr., E. Jankowska-Gan, S. Kusaka, Q. Xu, J. M. Schultz, T. D. Oberley, H. Hu, M. M. Hamawy, et al. Metastable Tolerance to Rhesus Monkey Renal Transplants Is Correlated with Allograft TGF-{beta}1+CD4+ T Regulatory Cell Infiltrates J. Immunol., May 1, 2004; 172(9): 5753 - 5764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nakamura, A. Kitani, I. Fuss, A. Pedersen, N. Harada, H. Nawata, and W. Strober TGF-{beta}1 Plays an Important Role in the Mechanism of CD4+CD25+ Regulatory T Cell Activity in Both Humans and Mice J. Immunol., January 15, 2004; 172(2): 834 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Olman and M. A. Matthay Transforming growth factor-{beta} induces fibrosis in immune cell-depleted lungs Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L522 - L526. [Full Text] [PDF]
|
|
|
|
|
|
Y. D. Xu, J. Hua, A. Mui, R. O'Connor, G. Grotendorst, and N. Khalil Release of biologically active TGF-{beta}1 by alveolar epithelial cells results in pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L527 - L539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hugo The thrombospondin 1-TGF-{beta} axis in fibrotic renal disease Nephrol. Dial. Transplant., July 1, 2003; 18(7): 1241 - 1245. [Full Text] [PDF]
|
|
|
|
|
|
T. Oida, X. Zhang, M. Goto, S. Hachimura, M. Totsuka, S. Kaminogawa, and H. L. Weiner CD4+CD25- T Cells That Express Latency-Associated Peptide on the Surface Suppress CD4+CD45RBhigh-Induced Colitis by a TGF-{beta}-Dependent Mechanism J. Immunol., March 1, 2003; 170(5): 2516 - 2522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Annes, J. S. Munger, and D. B Rifkin Making sense of latent TGF{beta} activation J. Cell Sci., January 15, 2003; 116(2): 217 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsuoka, T. Arai, M. Mori, S. Goya, H. Kida, H. Morishita, H. Fujiwara, I. Tachibana, T. Osaki, and S. Hayashi A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L103 - L112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Masli, B. Turpie, K. H. Hecker, and J. W. Streilein Expression of Thrombospondin in TGF{beta}-Treated APCs and Its Relevance to Their Immune Deviation-Promoting Properties J. Immunol., March 1, 2002; 168(5): 2264 - 2273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Howat, S. T. Holgate, and P. M. Lackie TGF-beta isoform release and activation during in vitro bronchial epithelial wound repair Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L115 - L123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Khalil, T V Parekh, R O'Connor, N Antman, W Kepron, T Yehaulaeshet, Y D Xu, and L I Gold Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (Tbeta R-I and Tbeta R-II) in idiopathic pulmonary fibrosis Thorax, December 1, 2001; 56(12): 907 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Lee, R. J. Homer, Z. Zhu, S. Lanone, X. Wang, V. Koteliansky, J. M. Shipley, P. Gotwals, P. Noble, Q. Chen, et al. Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor {beta}1 J. Exp. Med., September 17, 2001; 194(6): 809 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nakamura, A. Kitani, and W. Strober Cell Contact-dependent Immunosuppression by CD4+CD25+ Regulatory T Cells Is Mediated by Cell Surface-bound Transforming Growth Factor {beta} J. Exp. Med., September 4, 2001; 194(5): 629 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Coutts, G. Chen, N. Stephens, S. Hirst, D. Douglas, T. Eichholtz, and N. Khalil Release of biologically active TGF-{beta} from airway smooth muscle cells induces autocrine synthesis of collagen Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L999 - L1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chamberlain, J. Gunn, S. E. Francis, C. M. Holt, N. D. Arnold, D. C. Cumberland, M. W.J. Ferguson, and D. C. Crossman TGF{beta} is active, and correlates with activators of TGF{beta}, following porcine coronary angioplasty Cardiovasc Res, April 1, 2001; 50(1): 125 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yehualaeshet, R. O'Connor, A. Begleiter, J. E. Murphy-Ullrich, R. Silverstein, and N. Khalil A CD36 Synthetic Peptide Inhibits Bleomycin-Induced Pulmonary Inflammation and Connective Tissue Synthesis in the Rat Am. J. Respir. Cell Mol. Biol., August 1, 2000; 23(2): 204 - 212. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Janabi, S. Yamashita, K.-i. Hirano, N. Sakai, H. Hiraoka, K. Matsumoto, Z. Zhang, S. Nozaki, and Y. Matsuzawa Oxidized LDL-Induced NF-{kappa}B Activation and Subsequent Expression of Proinflammatory Genes Are Defective in Monocyte-Derived Macrophages From CD36-Deficient Patients Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1953 - 1960. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
